Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-13 5:06 pm Unchanged | 2026-04-09 | 13D | DAY ONE BIOPHARMACEUTICALS INC DAWN | AI Day1 LLC | 12,929,322 12.520% | 0 (Unchanged) | Filing History |
| 2026-04-07 1:22 pm Sale | 2026-03-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 23,640 0.000% | -5,693,368 (-99.59%) | Filing History |
| 2026-03-26 5:42 pm Sale | 2026-03-13 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | VANGUARD GROUP INC | 0 0.000% | -4,769,746 (Position Closed) | Filing History |
| 2026-03-19 4:46 pm Purchase | 2026-03-12 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Glazer Capital LLC | 5,615,390 5.400% | 5,615,390 (New Position) | Filing History |
| 2026-02-17 4:06 pm Purchase | 2025-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Vestal Point Capital LP | 5,200,000 5.100% | 5,200,000 (New Position) | Filing History |
| 2026-02-05 1:20 pm Sale | 2025-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 5,717,008 5.600% | -4,380,660 (-43.38%) | Filing History |
| 2025-11-05 11:30 am Sale | 2025-09-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 10,097,668 9.900% | -1,245,031 (-10.98%) | Filing History |
| 2025-08-14 6:00 pm Sale | 2025-06-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA Capital Management, L.P. | 0 0.000% | -5,755,577 (Position Closed) | Filing History |
| 2025-08-06 11:56 am Sale | 2025-06-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 11,342,699 11.200% | -1,544,768 (-11.99%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | BlackRock Inc. BLK | 5,849,917 5.800% | 1,037,610 (+21.56%) | Filing History |
| 2025-04-28 5:45 pm Sale | 2025-03-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | BlackRock Inc. BLK | 4,812,307 4.700% | -313,764 (-6.12%) | Filing History |
| 2025-02-14 6:31 pm Sale | 2024-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA Capital Management, L.P. | 5,755,577 5.700% | -2,054,275 (-26.30%) | Filing History |
| 2025-02-12 09:28 am Purchase | 2024-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 12,887,467 12.800% | 1,600,140 (+14.18%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Atlas Venture Fund XI, L.P. | 4,869,681 5.500% | -1,178,137 (-19.48%) | Filing History |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 11,287,327 11.192% | 3,874,947 (+52.28%) | Filing History |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 7,412,380 7.539% | 3,444,214 (+86.80%) | Filing History |
| 2024-08-05 5:05 pm Unchanged | 2024-08-01 | 13D | DAY ONE BIOPHARMACEUTICALS INC DAWN | AI Day1 LLC | 12,929,322 13.150% | 0 (Unchanged) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA Capital Management, L.P. | 7,809,852 9.000% | 769,230 (+10.93%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | VANGUARD GROUP INC | 4,769,746 5.480% | 4,769,746 (New Position) | Filing History |
| 2024-02-09 4:08 pm Purchase | 2023-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Atlas Venture Fund XI, L.P. | 6,047,818 6.900% | 39,284 (+0.65%) | Filing History |